Peijia Medical (HKSE:09996) Debt-to-Equity : 0.08 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical Debt-to-Equity?

Peijia Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$3.1 Mil. Peijia Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$202.4 Mil. Peijia Medical's Total Stockholders Equity for the quarter that ended in Jun. 2023 was HK$2,673.7 Mil. Peijia Medical's debt to equity for the quarter that ended in Jun. 2023 was 0.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Peijia Medical's Debt-to-Equity or its related term are showing as below:

HKSE:09996' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.03 Med: 0 Max: 0.08
Current: 0.1

During the past 6 years, the highest Debt-to-Equity Ratio of Peijia Medical was 0.08. The lowest was -0.03. And the median was 0.00.

HKSE:09996's Debt-to-Equity is ranked better than
68.94% of 705 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs HKSE:09996: 0.10

Peijia Medical Debt-to-Equity Historical Data

The historical data trend for Peijia Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical Debt-to-Equity Chart

Peijia Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.05

0.10

Peijia Medical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial						-	0.02	0.05	0.08	0.10

Competitive Comparison of Peijia Medical's Debt-to-Equity

For the Medical Devices subindustry, Peijia Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Peijia Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Peijia Medical's Debt-to-Equity falls into.

Peijia Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Peijia Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(65.834	+	81.433)	/	2945.463
	=	0.05

Peijia Medical's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.099	+	202.395)	/	2673.747
	=	0.08

Peijia Medical (HKSE:09996) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Peijia Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Peijia Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Peijia Medical (HKSE:09996) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN

Website

https://www.peijiamedical.com

Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.

Executives

Jinnius Drive Trust	2103 Interests held jointly with another person
Xinyue International Limited	2103 Interests held jointly with another person
Ye Hong	2103 Interests held jointly with another person
Zhang Ping Ye	2103 Interests held jointly with another person
Zhang Yi	2301 Trustee
Hanlindale Trust	2103 Interests held jointly with another person
Hillhouse Investment Management, Ltd.	2102 Investment manager
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited	2101 Beneficial owner
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Shi Yi	2201 Interest of corporation controlled by you

Peijia Medical (HKSE:09996) Headlines

No Headlines